Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
60%(3 trials)

Phase Distribution

Ph phase_3
1
17%
Ph phase_4
1
17%
Ph not_applicable
2
33%
Ph phase_1
1
17%
Ph phase_2
1
17%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(5)

Detailed Status

Completed5
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 31 (16.7%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

completed583%
not_yet_recruiting117%

Recent Activity

0 active trials
Showing 5 of 6
not_yet_recruitingphase_4

Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers

NCT07681076
completedphase_3

Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin

NCT02112578
completednot_applicable

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

NCT02625181
completednot_applicable

Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients

NCT00641797
completedphase_2

Meclizine as a Potential Smoking Cessation Treatment

NCT01443858
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07681076Phase 4

Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers

Not Yet Recruiting
NCT02112578Phase 3

Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin

Completed
NCT02625181Not Applicable

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

Completed
NCT00641797Not Applicable

Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients

Completed
NCT01443858Phase 2

Meclizine as a Potential Smoking Cessation Treatment

Completed
NCT01537471Phase 1

The Effects of Antihistamines on Pre-Pulse Inhibition

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6